BEVACIZUMAB IN COMBINATION WITH TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY BEVACIZUMAB, TEMOZOLOMIDE, AND IRINOTECAN FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
Publication
, Conference
Vredenburgh, J; Desjardins, A; Reardon, D; Rich, J; Kirkpatrick, J; Gururangan, S; Bailey, L; Friedman, A; Bigner, D; Friedman, H
Published in: NEURO-ONCOLOGY
October 1, 2008
Duke Scholars
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
October 1, 2008
Volume
10
Issue
5
Start / End Page
836 / 837
Location
Las Vegas, NV
Publisher
OXFORD UNIV PRESS INC
Conference Name
13th Annual Meeting of the Society-for-Neuro-Oncology (SNO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Vredenburgh, J., Desjardins, A., Reardon, D., Rich, J., Kirkpatrick, J., Gururangan, S., … Friedman, H. (2008). BEVACIZUMAB IN COMBINATION WITH TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY BEVACIZUMAB, TEMOZOLOMIDE, AND IRINOTECAN FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME. In NEURO-ONCOLOGY (Vol. 10, pp. 836–837). Las Vegas, NV: OXFORD UNIV PRESS INC.
Vredenburgh, James, Annick Desjardins, David Reardon, Jeremy Rich, John Kirkpatrick, Sridharan Gururangan, Leighann Bailey, Allan Friedman, Darell Bigner, and Henry Friedman. “BEVACIZUMAB IN COMBINATION WITH TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY BEVACIZUMAB, TEMOZOLOMIDE, AND IRINOTECAN FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME.” In NEURO-ONCOLOGY, 10:836–37. OXFORD UNIV PRESS INC, 2008.
Vredenburgh J, Desjardins A, Reardon D, Rich J, Kirkpatrick J, Gururangan S, et al. BEVACIZUMAB IN COMBINATION WITH TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY BEVACIZUMAB, TEMOZOLOMIDE, AND IRINOTECAN FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME. In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2008. p. 836–7.
Vredenburgh, James, et al. “BEVACIZUMAB IN COMBINATION WITH TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY BEVACIZUMAB, TEMOZOLOMIDE, AND IRINOTECAN FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME.” NEURO-ONCOLOGY, vol. 10, no. 5, OXFORD UNIV PRESS INC, 2008, pp. 836–37.
Vredenburgh J, Desjardins A, Reardon D, Rich J, Kirkpatrick J, Gururangan S, Bailey L, Friedman A, Bigner D, Friedman H. BEVACIZUMAB IN COMBINATION WITH TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY BEVACIZUMAB, TEMOZOLOMIDE, AND IRINOTECAN FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2008. p. 836–837.
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
October 1, 2008
Volume
10
Issue
5
Start / End Page
836 / 837
Location
Las Vegas, NV
Publisher
OXFORD UNIV PRESS INC
Conference Name
13th Annual Meeting of the Society-for-Neuro-Oncology (SNO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences